Type II endoleak: from treatment of a complication to prevention.
Salvatore
S
Ronsivalle
Francesca
F
Faresin
Francesca
F
Franz
Carlo
C
Rettore
Mario
M
Zanchetta
Armando
A
Olivieri
D000783:Aneurysm / Q000191:economics / Q000503:physiopathology / Q000601:surgery*; D001807:Blood Vessel Prosthesis / Q000191:economics; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000191:economics / Q000295:instrumentation* / Q000401:mortality; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D004621:Embolization, Therapeutic / Q000191:economics; D057867:Endoleak / Q000191:economics / Q000209:etiology / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy*; D057510:Endovascular Procedures / Q000009:adverse effects / Q000191:economics / Q000295:instrumentation* / Q000401:mortality; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage* / Q000191:economics; D017721:Hospital Costs; D006801:Humans; D007558:Italy; D053208:Kaplan-Meier Estimate; D011474:Prosthesis Design; D011475:Prosthesis Failure; D013997:Time Factors
D015718:Fibrin Tissue Adhesive